167 related articles for article (PubMed ID: 2920977)
21. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
Takada A; Takada Y
Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
[TBL] [Abstract][Full Text] [Related]
22. Studies on the mechanism of the antifibrinolytic action of tranexamic acid.
Hoylaerts M; Lijnen HR; Collen D
Biochim Biophys Acta; 1981 Feb; 673(1):75-85. PubMed ID: 7193484
[No Abstract] [Full Text] [Related]
23. The activation of Glu- and Lys-plasminogens by streptokinase: effects of fibrin, fibrinogen and their degradation products.
Takada A; Takada Y; Sugawara Y
Thromb Res; 1985 Feb; 37(3):465-75. PubMed ID: 3992529
[TBL] [Abstract][Full Text] [Related]
24. Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.
Takada Y; Takada A
Haemostasis; 1987; 17(1-2):1-7. PubMed ID: 3596355
[TBL] [Abstract][Full Text] [Related]
25. Effects of fibrin on the enhanced activation of plasminogen by urokinase and tissue plasminogen activator: role of cross-link.
Takada A; Watahiki Y; Takada Y
Thromb Res; 1986 Mar; 41(5):605-13. PubMed ID: 3083529
[TBL] [Abstract][Full Text] [Related]
26. The beneficial effect of lys-plasminogen upon the thrombolytic efficacy of urokinase in a dog model of peripheral arterial thrombosis.
Badylak SF; Voytik SL; Henkin J; Burke S; Sasahara AA; Simmons A
Haemostasis; 1991; 21(5):278-85. PubMed ID: 1806456
[TBL] [Abstract][Full Text] [Related]
27. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
Suenson E; Lützen O; Thorsen S
Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
[TBL] [Abstract][Full Text] [Related]
28. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
Liu JN; Gurewich V
Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
[TBL] [Abstract][Full Text] [Related]
29. Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA.
Takada Y; Urano T; Takada A
Thromb Res; 1994 Mar; 73(5):301-11. PubMed ID: 8016815
[TBL] [Abstract][Full Text] [Related]
30. Comparison of kinetic parameters of the activation of Glu-plasminogen by tissue plasminogen activator obtained from various sources.
Takada A; Sugawara Y; Takada Y
Haemostasis; 1988; 18(2):117-25. PubMed ID: 3137140
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
Takada A; Takada Y
Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
[TBL] [Abstract][Full Text] [Related]
32. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
Takada Y; Takada A
Thromb Res; 1979; 16(5-6):865-9. PubMed ID: 160629
[No Abstract] [Full Text] [Related]
33. Effect of fucoidan during activation of human plasminogen.
Doctor VM; Hill C; Jackson GJ
Thromb Res; 1995 Aug; 79(3):237-47. PubMed ID: 8533120
[TBL] [Abstract][Full Text] [Related]
34. Conformational change of plasminogen: effects of N-terminal peptides of Glu-plasminogen.
Takada Y; Urano T; Takada A
Thromb Res; 1993 Apr; 70(2):151-9. PubMed ID: 8391730
[TBL] [Abstract][Full Text] [Related]
35. Autoradiographic and immunoblotting analyses of the activation pathways of plasminogen by urokinase and tissue plasminogen activator in the plasma or clotted plasma.
Takada A; Yoshida M; Takada Y
Thromb Res; 1988 Jan; 49(2):193-204. PubMed ID: 3129815
[TBL] [Abstract][Full Text] [Related]
36. Reexamination of the extent of the activation of Lys78 plasminogen by tissue plasminogen activator in the presence of polymerized fibrin.
Urano T; Takada Y; Ihara H; Takada A
Haemostasis; 1996; 26(4):220-7. PubMed ID: 8872134
[TBL] [Abstract][Full Text] [Related]
37. Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.
Takada A; Takada Y; Sugawara Y
Haemostasis; 1988; 18(2):106-12. PubMed ID: 3410360
[TBL] [Abstract][Full Text] [Related]
38. Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).
Fears R; Dodd I; Ferres H; Robinson JH
Biochem J; 1990 Mar; 266(3):693-6. PubMed ID: 2139324
[TBL] [Abstract][Full Text] [Related]
39. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
Liu JN; Pannell R; Gurewich V
J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775
[TBL] [Abstract][Full Text] [Related]
40. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
Takada A; Takada Y
Thromb Res; 1989 Sep; 55(6):717-25. PubMed ID: 2551068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
